Effects of treatment with formoterol on bronchoprotection against methacholine

American Journal of Medicine

Volumn 104, Issue 5, 1998, Pages 431-438

  Lipworth, Brian ^a   Tan, Soong ^a   Devlin, Martin ^a   Aiken, Trevor ^b   Baker, Rachel ^b   Hendrick, David ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; FLUTICASONE; FORMOTEROL; METHACHOLINE; TERBUTALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BRONCHODILATATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FORCED EXPIRATORY FLOW; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYPHYLAXIS; TREATMENT PLANNING;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; STEROIDS; TERBUTALINE; TIME FACTORS;

EID: 0032076892     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00086-2     Document Type: Article

References (19)

1. 1. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health, Publication No. 97-4051, 1997.
2. 2. Greening AP, Ind PW, Northfield M, Shore G. Added salmeterol versus higher dose corticosteroid in asthma patients with symptoms on existing inhaled steroid. Lancet. 1994;344:219-224.
3. 3. Woolcock A, Lundback B, Rnngdal N, Jacqes L. Comparison and addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med. 1996;153:1481-1488.
4. 4. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. NEJM. 1997; 337:1405-1411.
5. 5. Cockcroft DW, Swystun VA. Functional antagonism tolerance produced by inhaled beta 2-agonists. Thorax. 1996;51:1051-1056.
6. 6. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis. 1987;36:225-244.
7. 7. Connolly MJ, Avery AJ, Walters EH, Hendrick DJ. The relationship between bronchial responsiveness to methacholine and bronchial responsiveness to histamine in asthmatic patients. Pulm Pharmacol. 1988;1:53-58.
8. 8. Beach JR, Jung CL, Avery HA, et al. Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response. Thorax. 1993; 48:239-243.
9. 2-adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients. Thorax. 1995;50:497-504.
10. 10. Rabe KF, Jorres R, Nowak D, et al. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am Rev Respir Dis. 1997;147;1436-1441.
11. 11. Lipworth BJ, Aziz I, Tan KS. Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once daily formoterol. Eur Respir J. 1997;10(suppl 25):11S-12S.
12. 2-agonists: is there cause for concern? Drug Safety. 1997;16:295-308.
13. 13. Booth H, Bish R, Walatons J, et al. Salmeterol tachyphylaxis in steroid treated asthmatic patients. Thorax. 1996;51:1100-1104.
14. 14. Grove A, Lipworth BJ. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet. 1995;346: 210-216.
15. 15. Kalra S, Swystun VA, Bahagat R, Cockcroft DW. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest. 1996;109:953-956.
16. 2-agonists. Am J Respir Crit Care Med. 1996;154:1603-1607.
17. 2-adrenergic receptors in vivo. J Clin Invest. 1995:96:99-106.
18. 18. Samuelson WN, Davis AO. Hydrocortisone induced reversal of β-adrenergic receptor uncoupling. Am Rev Respir Dis. 1984;130: 1023-1026.
19. 19. Tan KS, Grove A, McLean A, et al. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am J Respir Crit Care Med. 1997;156:28-35.